Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|August 29, 2024
The Influence of SARS-CoV-2 Infection on the Development of Selected Neurological DiseasesKlaudia Kryńska, Katarzyna Kuliś, Wiktoria Mazurek, et al.
International Journal of Molecular Sciences|May 27, 2026
Diagnostic Usefulness of SP-D, CCL2/MCP-1, and IL-18 in Assessing Respiratory Function and Risk of Pulmonary Fibrosis in COVID-19 PatientsBogdan Cylwik, Kacper Gan, Marcin Kazberuk, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 28, 2018
Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patientsMonika Zajkowska, Monika Zbucka-Krętowska, Iwona Sidorkiewicz, et al.
Biomedicines|June 27, 2024
The Impact of COVID-19 on the Guillain-Barré Syndrome IncidenceMagdalena Kopańko, Magdalena Zabłudowska, Monika Zajkowska, et al.
Cancers|November 25, 2023
Higher Content but No Specific Activity in Gelatinase B (MMP-9) Compared with Gelatinase A (MMP-2) in Human Renal CarcinomaGrzegorz Młynarczyk, Monika Gudowska-Sawczuk, Barbara Mroczko, et al.
Journal of Clinical Medicine|September 10, 2021
Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis CDagmara Przekop, Jakub Klapaczynski, Agnieszka Grytczuk, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|August 15, 2017
[The plasma levels and diagnostic utility of matrix metalloproteinase-9 and CA 125 in cervical cancer patients]Emilia Lubowicka, Ewa Gacuta, Monika Zajkowska, et al.
International Journal of Molecular Sciences|October 14, 2022
Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2Monika Gudowska-Sawczuk, Anna Moniuszko-Malinowska, Sara Pączek, et al.
Pathology Oncology Research : POR|March 2, 2019
Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC AnalysisEmilia Lubowicka, Monika Zbucka-Kretowska, Iwona Sidorkiewicz, et al.
International Journal of Environmental Research and Public Health|October 14, 2022
Higher Content but Not Activity of Stromelysin-2 (MMP-10) in Comparison to Stromelysin-1 (MMP-3) in Human Renal CarcinomaJacek Kudelski, Grzegorz Młynarczyk, Monika Gudowska-Sawczuk, et al.
Pageof 13